Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome

Figure 2

Correlation of 87 rectal cancer patients CD4+ (a, c, and e) or CD8+ (b, d, and f) cells’ apoptotic rates regarding the 2 Gy (a and b), 8 Gy (c and d), and combination of 2 Gy and 10 μg/mL Oxaliplatin (e and f) treatment. The diagrams include the coefficients of determination (), value, and the trend line.

(a)

(b)

(c)

(d)

(e)

(f)